Genes2Me (G2M) is a leading Indian manufacturer of high-quality, certified In Vitro Diagnostic (IVD) solutions, with a strong emphasis on affordability and innovation in patient care. Since 2016, G2M has consistently set industry benchmarks with its CE-IVD, ISO-13485, and ISO 9001:2016 certified diagnostic kits, all proudly made in India.
A key focus of G2M’s advanced product portfolio is Next Generation Sequencing (NGS) clinical panels, tailored to support precision medicine. These panels cover a wide range of critical areas including oncology, liquid biopsy, cardiovascular diseases, neurological disorders, and HLA typing. Designed for broad accessibility, the panels are compatible with major sequencing platforms: Thermo Fisher, MGI, and Illumina.
To enhance the clinical utility of its NGS solutions, G2M offers a cloud-based bioinformatics software platform, ensuring fast, flexible, and user-friendly interpretation of complex sequencing data. The company’s NGS solutions are backed by rigorous quality standards—its laboratories are NABL, ISO 9001, and ISO 14001 accredited, and the manufacturing facility is DCGI-approved and ISO 13485 certified.
Genes2Me continues to pioneer impactful technologies in molecular diagnostics, positioning itself at the forefront of personalized medicine in India and beyond.